Invention Grant
- Patent Title: Ketogenic diet compatible fenfluramine formulation
-
Application No.: US16866083Application Date: 2020-05-04
-
Publication No.: US11458111B2Publication Date: 2022-10-04
- Inventor: Khawla Abu-Izza , David Hickman , Glenn Morrison , Brooks M. Boyd
- Applicant: ZOGENIX INTERNATIONAL LIMITED
- Applicant Address: GB Berkshire
- Assignee: ZOGENIX INTERNATIONAL LIMITED
- Current Assignee: ZOGENIX INTERNATIONAL LIMITED
- Current Assignee Address: GB Berkshire
- Agency: Bozicevic, Field & Francis LLP
- Agent Karl Bozicevic
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61P25/08 ; A23L33/10 ; A61K9/08 ; A61K47/26 ; A61K47/14 ; A61K47/12 ; A23L33/00 ; A61K47/38

Abstract:
A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.
Public/Granted literature
- US20200261380A1 KETOGENIC DIET COMPATIBLE FENFLURAMINE FORMULATION Public/Granted day:2020-08-20
Information query